}})
Key Takeaways
- iTind stands for Temporary Implanted Nitinol Device. It reshapes your prostate without cutting or burning.
- The device is removed after 5 to 7 days. Nothing stays inside permanently.
- The procedure is done in a doctor's office or outpatient clinic, mostly under local anesthesia.
- No catheter is needed for most patients after the procedure.
- Clinical data show results lasting up to 6.6 years for symptom relief and urinary flow.
- No new sexual dysfunction was recorded in clinical trials, including no erectile dysfunction or retrograde ejaculation.
- In 2025, CMS introduced CPT codes 53865 and 53866 for iTind insertion and removal, standardizing Medicare billing.
- The device supply price under the 2025 Medicare Physician Fee Schedule is $2,972.50.
- The 2023 AUA guidelines formally recognize iTind under Temporary Implanted Prostatic Devices (TIPD).
- iTind suits men aged 50 and older with small to medium prostates who want BPH treatment without surgery.
You wake up three times a night. The urine stream is weak. The urge hits without warning. Medications helped at first. Then they stopped. Surgery feels like too much, too soon.
This is where the iTind procedure steps in. A minimally invasive BPH treatment designed to sit between daily pills and the operating table. No cutting. No permanent implant. No hospital stay.
This guide covers how the iTind device works, who it suits, clinical results, side effects, and 2026 costs.
What is the iTind Device and How Does It Work?
Men's urological health declines silently. The prostate grows around the urethra and squeezes it shut. The result is lower urinary tract symptoms (LUTS): frequent urination, weak flow, incomplete emptying, and sudden urgency.
The iTind device is a temporary, implanted nitinol device made from a nickel-titanium alloy. Nitinol is biocompatible and shape-memory, holding its preset form at body temperature. Think of it like a spring-loaded scaffold placed exactly where the blockage is.
Here is how the prostate reshaping procedure works:
- A urologist places the device inside the prostatic urethra using a cystoscope.
- It expands and applies gentle outward pressure on three points of the urethral wall.
- Over 5 to 7 days, tissue reshapes and widens, functioning similarly to a nitinol stent prostate approach but leaving nothing permanently behind.
- After removal, the prostate holds its new open shape, and BPH urinary flow improvement begins.
Unlike a prostate urethral lift, which leaves permanent implants inside, iTind removes completely. That matters to men who do not want foreign hardware in their bodies long term.
Who is a Good Candidate?
iTind works best for men who:
- Are 50 years or older with confirmed BPH-related urinary outflow obstruction
- Have tried BPH treatment without surgery, but found medications insufficient or intolerable
- Are not ready for invasive surgery
- Want non-surgical enlarged prostate relief with no permanent implant
- Have a small to medium-sized prostate
Men with very large prostates, active infections, or specific anatomical conditions may not qualify. A urologist consultation confirms eligibility.
The iTind Procedure: What Happens Step by Step
This is a local anesthesia prostate procedure. Most men are surprised by how simple it is.
Placement visit: Your urologist guides the iTind into the prostatic urethra via cystoscope. Around 10 to 15 minutes. You go home the same day.
Days 1 to 7 at home: The device reshapes the prostate. Mild urgency or light discomfort is manageable with over-the-counter pain relievers.
Removal visit: A brief outpatient prostate procedure. Device removed. No stitches.
After removal: BPH urinary flow improvement often starts immediately and builds over the following weeks.
What Do the Clinical Results Show?
iTind is backed by peer-reviewed, published data:
- Significant IPSS (International Prostate Symptom Score) reductions in multicenter randomized trials.
- Consistent BPH urinary flow improvement in maximum urine flow rate (Qmax).
- Symptom relief lasting up to 6.6 years in clinical follow-up data.
- Fewer than 5% of patients needed a catheter. True BPH without catheter recovery.
- No new sexual dysfunction across all iTind clinical studies.
The 2023 AUA guidelines formally include iTind under Temporary Implanted Prostatic Devices (TIPD), a recognized BPH minimally invasive surgical therapy (MIST).
iTind Side Effects: What to Expect
Every benign prostatic hyperplasia treatment carries some risk. iTind is no exception. Here is what clinical data and patient experience show:
Common and temporary (during the 5 to 7 day treatment period):
- Urinary urgency and mild pelvic discomfort
- Burning sensation during urination
- Blood in urine (hematuria)
Rare: Urinary tract infection or acute urinary retention.
What iTind side effects do NOT include: No retrograde ejaculation. No new erectile dysfunction. No permanent sexual damage. A key win for men focused on sexual function preservation and BPH treatment.
iTind Cost and Medicare Coverage in 2026
iTind cost is one of the first questions men ask. Here is the current picture.
The iTind device supply price was established at $2,972.50 under the 2025 Medicare Physician Fee Schedule. Total costs, including physician fees, facility charges, and anesthesia, vary by location. Always request a full itemized estimate from your urologist's billing office before booking.
CPT codes 53865 and 53866 for iTind insertion and removal are active across all care settings: physician offices, hospital outpatient departments, and ambulatory surgical centers.
Key 2026 Medicare updates:
- The CY 2026 Medicare Physician Fee Schedule, effective January 1, 2026, now carries two separate conversion factors: $33.57 for qualifying Advanced APM practitioners and $33.40 for others. Both represent meaningful increases after years of cuts.
- A -2.5% efficiency adjustment applies to work RVUs for established codes, including 53865 and 53866. The change is modest. Your billing team will have the exact updated figures.
- Office-based urology payments increased approximately 5% in 2026, while facility-based payments dropped around 10%. Since iTind is most often done in a physician's office, non-facility access may improve.
Private insurance in 2026: Some commercial payers still classify iTind as investigational.
What Are Lower Urinary Tract Symptoms (LUTS)?
Lower urinary tract symptoms (LUTS) are the everyday signs that your prostate is pressing on your urethra. In men over 50, LUTS are most commonly caused by BPH. Left unmanaged, they quietly chip away at sleep, confidence, and daily comfort.
LUTS fall into two categories:
Storage Symptoms (how your bladder holds urine):
- Frequency - needing to urinate more than 8 times a day
- Urgency - a sudden, strong urge that is hard to hold back
- Nocturia - waking two or more times at night to urinate
- Urge incontinence - leaking urine before reaching the bathroom
Voiding Symptoms (how your bladder empties urine):
- Weak stream - urine trickles rather than flows steadily
- Hesitancy - difficulty starting urination even when the urge is strong
- Straining - needing to push or bear down to urinate
- Intermittency - urine flow that stops and starts mid-stream
- Incomplete emptying - feeling the bladder is never fully empty
- Terminal dribble - a slow drip at the end of urination
Why LUTS Matter Beyond Inconvenience
Most men dismiss these symptoms as normal aging. They are common. But they are not something you simply have to live with.
Untreated LUTS can lead to urinary tract infections, bladder damage, and in severe cases, complete urinary retention. Broken sleep, social anxiety, and avoiding activities all affect quality of life significantly.
LUTS severity is measured using the International Prostate Symptom Score (IPSS), a standard questionnaire your urologist uses to guide treatment decisions.
iTind vs UroLift vs Rezum vs TURP
UroLift vs iTind: Both are office-based minimally invasive BPH treatment options. UroLift is a prostate urethral lift using permanent implants to hold prostate lobes open. iTind leaves nothing behind. UroLift may suit larger prostates. iTind suits men who want zero permanent hardware.
Rezum vs iTind: Rezum uses steam to destroy excess prostate tissue, offering 5 to 7 years of relief but requiring a post-procedure catheter for most patients and carrying some retrograde ejaculation risk. iTind reshapes tissue without heat, needs no catheter in most cases, and records no sexual dysfunction.
iTind vs TURP: TURP is the gold standard for enlarged prostate treatment. Most effective. But it requires hospital admission, spinal or general anesthesia, a 90% catheterization rate, and weeks of recovery. iTind is the BPH treatment without surgery option for men not ready for that.
Sexual Function Preservation: What the Studies Say
For many men, sexual function preservation in BPH treatment is the deciding factor, not just a nice feature.
TURP carries a well-documented retrograde ejaculation risk. Heat-based procedures like Rezum carry some risk, too. iTind uses only mechanical pressure, no heat, no cutting.
Published studies tracked de novo sexual dysfunction after iTind. Result: no new erectile dysfunction or retrograde ejaculation recorded. For men weighing BPH minimally invasive surgical therapy (MIST) options, iTind is one of the safest choices for sexual health.
Recovery Time After iTind
Recovery is fast compared to surgical options.
- Day of procedure: Go home the same day.
- Days 1 to 7: Device in place. Light activity. Discomfort is manageable.
- Removal day: Brief outpatient visit.
- Weeks 1 to 2: Rapid BPH urinary flow improvement. Most men resume normal routines.
Compare that to TURP's typical 4 to 6 week recovery. iTind is a different category entirely.
Conclusion
BPH does not have to mean pills that fail or surgery you are not ready for.
The iTind procedure is guideline-recognized, clinically proven, and built around men's urological health priorities: no permanent implant, no catheter in most cases, no sexual side effects, and same-day discharge. In 2026, iTind Medicare coverage is more accessible than ever with standardized CPT codes and an improved conversion factor.
No single enlarged prostate treatment fits every man. Talk to a urologist who offers iTind, UroLift, Rezum, and TURP. Make a decision built around your body and your life.
